An interventional study of telem healthassessment in Rash, Systemic Treatments and Tele-assessment, sponsored by Sligo General Hospital. Enrolling by invitation at 1 site in Ireland. Per ClinicalTrials.gov, last updated 2026-04-28.
Sponsored by Sligo General Hospital · Not applicable, Interventional, and Treatment
This study is being done to find out if video consultations (telemedicine) can be used to safely and effectively assess and manage skin problems caused by cancer treatments. Instead of always coming to the hospital for a face-to-face appointment, the patient may be able to use thier smartphone or computer to show your skin to a nurse or doctor over a secure video call. the researchers want to see if this is as good as a regular clinic visit, and whether patients and staff are happy with this new way of working.
68 studies on the registry are indexed under Exanthema; 11 are open to participants now.
This study's planned enrollment of 25 is below the median of 60 across 45 interventional studies indexed under Exanthema.
Browse Exanthema studies →Sligo General Hospital is the lead sponsor of 5 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:Participants must meet all of the following criteria:
Exclusion Criteria: Participants will be excluded if any of the following criteria apply:
use of telemedicine
Other: telem healthassessment
SOC is face to face assessment-this study aims to use telemedecine toassess Treatment related skin disorders
time to clinical resolution
Number of days from first AHOS contact to documented resolution (Grade 0-1).
Time frame: 6 weeks
Escalation in person review
Proportion of telemedicine patients requiring: * Conversion to face-to-face review * Emergency department attendance * Hospital admission
Time frame: 6 weeks
treatment modification reat
Proportion of telemedicine patients requiring: * Conversion to face-to-face review * Emergency department attendance * Hospital admission
Time frame: 6 weeks
unscheduled acute contact
Number of unplanned re-contacts with AHOS
Time frame: 6 weeks
Patient-Reported Endpoints -Quality of Life (QoL) and patient satisfaction
Instrument: QLQ administered: * Post initial assessment * At resolution or week 6
Time frame: 6 weeks
PDFs hosted by the registry, ClinicalTrials.gov.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sligo General Hospital